Risk Factors and Medical Symptoms associated With Electronic Vapor Product Use among adolescents and Young adults.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Benyo (2021)
Fingerprinting the volatile profile of traditional tobacco and e-cigarettes: a comparative study.
Nonclinical
Chemical
Analysis
Berenguer (2021)
Urinary volatomic profile of traditional tobacco smokers and electronic cigarettes users as a strategy to unveil potential health issues.
Individual Clinical
Biomarkers
Biomarkers Of Harm
Berenguer (2022)
Young Adults’ Vaping, Readiness to Quit, and Recent Quit Attempts: The Role of Co-use With Cigarettes and Marijuana.
Population Clinical
Cessation
ENDS
Berg (2021)
Consequences of Electronic-Cigarette Flavoring Exposure on the Immature Lung.
Individual Clinical
Respiratory Toxicity
Relative Health Effect Of User
Berkelhamer (2019)
Comparison of e-cigarette use characteristics between exclusive e-cigarette users and dual e-cigarette and conventional cigarette users: an on-line survey in France.
Individual Clinical
User Topography
Berlin (2019)
E-Cigarette Use and Risk of Cardiovascular Disease: a Longitudinal analysis of the PaTh Study (2013-2019).
Individual Clinical
Safety
Adverse Effects
Berlowitz (2022)
Cigarette‒E-cigarette Transitions and Respiratory Symptom Development.
Population Clinical
Likelihood Of Use
Berlowitz (2023)
Electronic Cigarettes for Smoking Cessation: The Gap Between Behavior in Smokers and Medical Education.
Population Clinical
Cessation
Tobacco
Bernstein (2022)
Reduced-risk warnings versus the US FDA-mandated addiction warning: The effects of e-cigarette warning variations on health risk perceptions.
Population Clinical
Effect Of Packaging & Labelling On Perception Of Risk
Berry (2019)